A post hoc study on gene panel analysis for the diagnosis of dystonia
(2017) In Movement Disorders 32(4). p.569-575- Abstract
Background: Genetic disorders causing dystonia show great heterogeneity. Recent studies have suggested that next-generation sequencing techniques such as gene panel analysis can be effective in diagnosing heterogeneous conditions. The objective of this study was to investigate whether dystonia patients with a suspected genetic cause could benefit from the use of gene panel analysis. Methods: In this post hoc study, we describe gene panel analysis results of 61 dystonia patients (mean age, 31 years; 72% young onset) in our tertiary referral center. The panel covered 94 dystonia-associated genes. As comparison with a historic cohort was not possible because of the rapidly growing list of dystonia genes, we compared the diagnostic workup... (More)
Background: Genetic disorders causing dystonia show great heterogeneity. Recent studies have suggested that next-generation sequencing techniques such as gene panel analysis can be effective in diagnosing heterogeneous conditions. The objective of this study was to investigate whether dystonia patients with a suspected genetic cause could benefit from the use of gene panel analysis. Methods: In this post hoc study, we describe gene panel analysis results of 61 dystonia patients (mean age, 31 years; 72% young onset) in our tertiary referral center. The panel covered 94 dystonia-associated genes. As comparison with a historic cohort was not possible because of the rapidly growing list of dystonia genes, we compared the diagnostic workup with and without gene panel analysis in the same patients. The workup without gene panel analysis (control group) included theoretical diagnostic strategies formulated by independent experts in the field, based on detailed case descriptions. The primary outcome measure was diagnostic yield; secondary measures were cost and duration of diagnostic workup. Results: Workup with gene panel analysis led to a confirmed molecular diagnosis in 14.8%, versus 7.4% in the control group (P = 0.096). In the control group, on average 3 genes/case were requested. The mean costs were lower in the gene panel analysis group (€1822/case) than in the controls (€2660/case). The duration of the workup was considerably shorter with gene panel analysis (28 vs 102 days). Conclusions: Gene panel analysis facilitates molecular diagnosis in complex cases of dystonia, with a good diagnostic yield (14.8%), a quicker diagnostic workup, and lower costs, representing a major improvement for patients and their families.
(Less)
- author
- publishing date
- 2017-04-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- cost, diagnostic yield, dystonia, gene panel analysis, next-generation sequencing
- in
- Movement Disorders
- volume
- 32
- issue
- 4
- pages
- 7 pages
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- scopus:85013006971
- pmid:28186668
- ISSN
- 0885-3185
- DOI
- 10.1002/mds.26937
- language
- English
- LU publication?
- no
- id
- 7bec599e-ec53-4055-9e16-8188f860cca5
- date added to LUP
- 2020-02-26 09:50:48
- date last changed
- 2024-04-03 03:33:35
@article{7bec599e-ec53-4055-9e16-8188f860cca5,
abstract = {{<p>Background: Genetic disorders causing dystonia show great heterogeneity. Recent studies have suggested that next-generation sequencing techniques such as gene panel analysis can be effective in diagnosing heterogeneous conditions. The objective of this study was to investigate whether dystonia patients with a suspected genetic cause could benefit from the use of gene panel analysis. Methods: In this post hoc study, we describe gene panel analysis results of 61 dystonia patients (mean age, 31 years; 72% young onset) in our tertiary referral center. The panel covered 94 dystonia-associated genes. As comparison with a historic cohort was not possible because of the rapidly growing list of dystonia genes, we compared the diagnostic workup with and without gene panel analysis in the same patients. The workup without gene panel analysis (control group) included theoretical diagnostic strategies formulated by independent experts in the field, based on detailed case descriptions. The primary outcome measure was diagnostic yield; secondary measures were cost and duration of diagnostic workup. Results: Workup with gene panel analysis led to a confirmed molecular diagnosis in 14.8%, versus 7.4% in the control group (P = 0.096). In the control group, on average 3 genes/case were requested. The mean costs were lower in the gene panel analysis group (€1822/case) than in the controls (€2660/case). The duration of the workup was considerably shorter with gene panel analysis (28 vs 102 days). Conclusions: Gene panel analysis facilitates molecular diagnosis in complex cases of dystonia, with a good diagnostic yield (14.8%), a quicker diagnostic workup, and lower costs, representing a major improvement for patients and their families.</p>}},
author = {{van Egmond, Martje E. and Lugtenberg, Coen H.A. and Brouwer, Oebele F. and Contarino, Maria Fiorella and Fung, Victor S.C. and Heiner-Fokkema, M. Rebecca and van Hilten, Jacobus J. and van der Hout, Annemarie H. and Peall, Kathryn J. and Sinke, Richard J. and Roze, Emmanuel and Verschuuren-Bemelmans, Corien C. and Willemsen, Michel A. and Wolf, Nicole I. and Tijssen, Marina A. and de Koning, Tom J.}},
issn = {{0885-3185}},
keywords = {{cost; diagnostic yield; dystonia; gene panel analysis; next-generation sequencing}},
language = {{eng}},
month = {{04}},
number = {{4}},
pages = {{569--575}},
publisher = {{John Wiley & Sons Inc.}},
series = {{Movement Disorders}},
title = {{A post hoc study on gene panel analysis for the diagnosis of dystonia}},
url = {{http://dx.doi.org/10.1002/mds.26937}},
doi = {{10.1002/mds.26937}},
volume = {{32}},
year = {{2017}},
}